top of page

Features & Benefits

Genes analyzed

  • LDLR

  • APOB

  • PCSK9

  • LDLRAP1

  • APOE

  • STAP1

Polygenic FH SNPs analyzed

  • rs629301

  • rs1564348

  • rs1800562

  • rs2479409

  • rs3757354

  • rs4299376

  • rs6511720

  • rs8017377

  • rs11220462

  • rs1367117

  • rs429358

  • rs7412

Sequencing of six SNPs involved in statin response

  • rs429358

  • rs7412

  • rs646776

  • rs4149056

  • rs3798220

  • rs10455872

  • Blood Borne Viruses
    Hepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
  • Enteric Viruses and Bacteria
    Clostridium difficile EHEC Norovirus Rotavirus
  • Human Adenovirus, Human Herpesvirus and Polyomavirus
    Human adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
  • Respiratory Viruses, Bacteria and Fungi
    Human adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
  • Tropical and other Viruses, Bacteria and Parasites
    AHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
devyserLogo2.png
61b721574992466120f95425_Singel_Orange_FH_NGS.jpg

Devyser FH NGS

 

Devyser FH NGS enables analysis of sequence variants in human genes implicated in Familial Hypercholesterolemia (FH) and polymorphisms associated with statin treatment effect.

 

For further information on the Devyser FH NGS Kit, click here.

To download the Devyser FH NGS Kit handbook, click here.

​

❮ BACK TO HEREDITARY        

❮ BACK TO DEVYSER MAIN 

Devyser FH NGS Anchor

Features & Benefits

  • Identify genetic basis of thrombotic event

  • Aid in therapy selection

  • Treatment optimisation

  • Determine need for prophylaxis

  • Estimate future thrombotic risk

61b720f9c60967c47f13088d_Singel_Lila_Thrombophilia.jpg
Devyser Thrombophilia Anchor
  • Blood Borne Viruses
    Hepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
  • Enteric Viruses and Bacteria
    Clostridium difficile EHEC Norovirus Rotavirus
  • Human Adenovirus, Human Herpesvirus and Polyomavirus
    Human adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
  • Respiratory Viruses, Bacteria and Fungi
    Human adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
  • Tropical and other Viruses, Bacteria and Parasites
    AHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus

Devyser Thrombophilia

 

The Devyser Thrombophilia assay offers a very simple procedure for testing six relevant mutations implicated in the risk of developing thrombophilia and venous thromboembolism.

 

It is a multiplex PCR reagent kit for simultaneous detection of six genetic risk factors associated with thrombophilia

 

For further information on the Devyser Thrombophilia Kit, click here.

To download the Devyser Thrombophilia Kit handbook, click here.

​

❮ BACK TO HEREDITARY        

❮ BACK TO DEVYSER MAIN 

Features & Benefits

  • Single tube PCR minimizes hands-on time

  • Single tube PCR reduces analysis times while minimizing the risk of sample mix up

  • A single mix allows testing of seven relevant risk factors for cardiovascular disease

  • Blood Borne Viruses
    Hepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
  • Enteric Viruses and Bacteria
    Clostridium difficile EHEC Norovirus Rotavirus
  • Human Adenovirus, Human Herpesvirus and Polyomavirus
    Human adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
  • Respiratory Viruses, Bacteria and Fungi
    Human adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
  • Tropical and other Viruses, Bacteria and Parasites
    AHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus

Devyser CVD

 

Devyser CVD is an in vitro diagnostic product for qualitative detection of genetic risk factors for the development of cardiovascular disease (CVD).

 

For further information on the Devyser CVD, click here.

To download the Devyser CVD handbook, click here.

​

❮ BACK TO HEREDITARY        

❮ BACK TO DEVYSER MAIN 

61b720dd88d4d50e55844602_Singel_Rosa_CVD.jpg
Devyser CVD Anchor

© 2025. SDT Molecular Pte Ltd. All Rights Reserved.

bottom of page